TENX
TENAX THERAPEUT (TENX)
NASDAQ
$10.79-$0.16 (-1.46%)
Price as of Jun 03, 2026 6:07 PM EDT
  • $314.9M
    Market Cap
  • 86.02%
    1-Year Change
  • Biotechnology
    Industry
Annual
Quarterly
12/31/2025
12/31/2024
12/31/2023
12/31/2022
Income Statement
Total Operating Revenue
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Cost of Revenue
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Gross Profit
0
N/A
0
N/A
0
N/A
0
-100.00%
Sales and Marketing Expense
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Research and Development Expense
-32.7M
+157.08%
-12.7M
+293.61%
-3.2M
-39.96%
-5.4M
-78.62%
Depreciation and Amortization Expense
N/A
N/A
0
-100.00%
7,570
+47.19%
5,143
+24.95%
Total Operating Expenses
56.4M
+189.24%
19.5M
+136.75%
8.2M
-25.50%
11.1M
-66.23%
Operating Profit
-56.4M
+189.24%
-19.5M
-336.75%
8.2M
+174.50%
-11.1M
-133.77%
Interest Income
3.8M
+99.53%
1.9M
N/A
N/A
N/A
9,191
N/A
Interest Expense
0
+100.00%
-23,000
-4.03%
-23,967
+439.43%
-4,443
N/A
Interest Income and Expense and Net
3.8M
+101.96%
1.9M
+7,990.02%
-23,967
-604.78%
4,748
N/A
Total Nonoperating Income and Expense
-33,000
-3,400.00%
1,000
+100.18%
-547,235
-6,054.03%
9,191
+868.49%
Income before Taxes
-56.4M
+189.24%
-19.5M
-336.75%
8.2M
+174.50%
-11.1M
-133.77%
Income Taxes
0
N/A
0
N/A
N/A
N/A
0
N/A
Extraordinary Items
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Net Income
-52.6M
+198.82%
-17.6M
-328.28%
7.7M
+169.79%
-11.0M
-65.98%
Net Income from Continuing Operations Applicable to Common
-52.6M
+198.82%
-17.6M
-328.28%
7.7M
+169.79%
-11.0M
-65.98%
Basic EPS and Net Income
-1.34
+16.52%
-1.15
N/A
N/A
N/A
N/A
N/A
Diluted EPS and Net Income
-1.34
+16.52%
-1.15
N/A
N/A
N/A
N/A
N/A
Basic Weighted Average Shares
39.2M
+156.80%
15.3M
+6,046.87%
248,447
-83.11%
1.5M
-92.85%
Diluted Weighted Average Shares
39.2M
+156.80%
15.3M
+6,046.87%
248,447
-83.11%
1.5M
-92.85%
Balance Sheet
Cash and Cash Equivalents
97.6M
+2.86%
94.9M
+868.65%
9.8M
+361.09%
2.1M
-61.97%
Short-Term Investments
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Cash and Cash Equivalents and Short-Term Investments
97.6M
+2.86%
94.9M
+868.65%
9.8M
+361.09%
2.1M
-61.97%
Total Current Assets
104.2M
+7.80%
96.7M
+727.54%
11.7M
+264.15%
3.2M
-43.60%
Accumulated Depreciation
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Property and Plant and Equipment and Net
N/A
N/A
N/A
N/A
0
-100.00%
7,189
+1.14%
Total Long-Term Assets
N/A
N/A
0
-100.00%
1,117
-88.31%
9,552
+13.24%
Total Assets
104.2M
+7.80%
96.7M
+727.46%
11.7M
+243.19%
3.4M
-43.18%
Income Taxes Payable
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Total Short-Term Debt
N/A
N/A
0
-100.00%
500,903
-19.77%
624,302
N/A
Total Current Liabilities
7.2M
+52.48%
4.7M
+30.85%
3.6M
+94.10%
1.8M
+18.15%
Total Long-Term Debt
N/A
N/A
N/A
N/A
N/A
N/A
624,302
N/A
Total Long-Term Liabilities
N/A
N/A
0
N/A
0
-100.00%
64,196
-65.03%
Total Liabilities
7.2M
+52.48%
4.7M
+30.85%
3.6M
+87.58%
1.9M
+9.41%
Retained Earnings
-367.5M
+16.71%
-314.9M
+5.92%
-297.3M
+2.66%
-289.5M
+3.97%
Total Stockholders Equity
97.1M
+5.52%
92.0M
+1,035.98%
8.1M
+442.50%
1.5M
-64.83%
Total Shares Outstanding
9.3M
+172.27%
3.4M
+1,046.87%
298,281
-86.98%
2.3M
-90.91%
Cash Flow
Cash from Operating Activities
-35.8M
+141.71%
-14.8M
+150.88%
-5.9M
-50.86%
-12.0M
+10.65%
Capital Expenditures
N/A
N/A
N/A
N/A
N/A
N/A
2,323
-55.77%
Cash from Investing Activities
N/A
N/A
0
-100.00%
2,843
+222.38%
-2,323
-100.51%
Dividends Paid
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Cash from Financing Activities
38.5M
-61.44%
99.9M
+636.01%
13.6M
+58.61%
8.6M
-12.14%
Financials Ratio
Gross Margin
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Operating Margin
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Return on Assets
-52.36%
+61.18%
-32.48%
-131.79%
102.20%
+143.46%
-235.14%
-53.44%
Return on Equity
-55.64%
+58.20%
-35.17%
-121.87%
160.79%
+141.75%
-385.12%
-47.40%
Revenue Growth
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Current Ratio
14.57
-29.30%
20.60
+532.43%
3.26
+87.61%
1.74
-52.26%
Cash Ratio
13.63
-32.54%
20.21
+640.26%
2.73
+137.56%
1.15
-67.81%
Debt-to-Equity Ratio
N/A
N/A
N/A
N/A
N/A
N/A
0.84
N/A
Debt-to-Assets Ratio
N/A
N/A
N/A
N/A
N/A
N/A
0.37
N/A

Earnings & Revenue History

Debt-to-Assets

Cash Flow